TOP Ships Inc. (NASDAQ:TOPS), an international ship-owning company, announced on 17 February that it has filed its Annual Report on Form 20-F, on February 14, 2014, for the year ended December 31, 2013. TOP Ships Inc. (NASDAQ:TOPS) shares after opening at $1.50 moved to $1.55 on last trade day and at the end of the day closed at $1.39. Company price to sales ratio in past twelve months was calculated as 4.03 and price to cash ratio as -. TOP Ships Inc. (NASDAQ:TOPS) showed a negative weekly performance of -2.80%.
Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage Biotech Company, announced yesterday the formation of a new Dermatology Scientific Advisory Board (SAB). Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) shares fell -7.92% in last trading session and ended the day on $5.70.
Flexion Therapeutics, Inc. (NASDAQ:FLXN) announced that CEO Michael Clayman, M.D., will present an overview of the company at the 13th Annual Needham Healthcare Conference. Dr. Clayman’s presentation is scheduled for April 9, 2014, at 1:40 p.m. Eastern Time. Flexion Therapeutics Inc. (NASDAQ:FLXN) shares moved down -3.85% in last trading session and was closed at $17.25, while trading in range of $15.45 – $18.23. Flexion Therapeutics Inc. (NASDAQ:FLXN) year to date (YTD) performance is 17.27%.
Ocera Therapeutics Inc. (NASDAQ:OCRX) generated $0.1 million in revenue for the year ended December 31, 2013 from royalty revenue from a licensing agreement compared with no revenue in 2012. Ocera Therapeutics Inc. (NASDAQ:OCRX) weekly performance is -9.38%. On last trading day company shares ended up $9.56. Ocera Therapeutics Inc. (NASDAQ:OCRX) distance from 50-day simple moving average (SMA50) is -29.82%. Analysts mean target price for the company is $22.50.
Leave a Reply